scispace - formally typeset
M

Marilyn J. Telen

Researcher at Duke University

Publications -  244
Citations -  11461

Marilyn J. Telen is an academic researcher from Duke University. The author has contributed to research in topics: Antigen & Cell adhesion molecule. The author has an hindex of 40, co-authored 226 publications receiving 9501 citations. Previous affiliations of Marilyn J. Telen include University of Pittsburgh & Stanford University.

Papers
More filters
Journal ArticleDOI

Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program.

Daniel Taliun, +205 more
- 10 Feb 2021 - 
TL;DR: The Trans-Omics for Precision Medicine (TOPMed) project as discussed by the authors aims to elucidate the genetic architecture and biology of heart, lung, blood and sleep disorders, with the ultimate goal of improving diagnosis, treatment and prevention of these diseases.
Posted ContentDOI

Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program

Daniel Taliun, +194 more
- 06 Mar 2019 - 
TL;DR: The nearly complete catalog of genetic variation in TOPMed studies provides unique opportunities for exploring the contributions of rare and non-coding sequence variants to phenotypic variation as well as resources and early insights from the sequence data.
Journal ArticleDOI

Evolution of adverse changes in stored RBCs.

TL;DR: Of clinical concern is that SNO levels, and their physiological correlate, RBC-dependent vasodilation, become depressed soon after collection, suggesting that even “fresh” blood may have developed adverse biological characteristics.
Journal ArticleDOI

CD44 — A molecule involved in leukocyte adherence and T-cell activation

TL;DR: This review brings together numerous divergent lines of investigation on the CD44 molecule, review the many functional roles attributed to it, and presents a unifying view of how, with numerous ligands, it may participate in several areas of normal immune cell function.
Journal ArticleDOI

Definitions of the phenotypic manifestations of sickle cell disease

TL;DR: An overview of the process to establish consensus definitions of the most frequently occurring complications of Sickle Cell Disease is provided and use of these definitions will support greater accuracy in genotype–phenotype studies, thereby achieving a better understanding of SCD pathophysiology.